Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).

Fig. 2

Representative images of the first ROADSTER patient enrolled on cohort 2

Figures 2a and 2b, and 2c show the axial, sagittal and coronal views of the T2-weighted MR images. Figures 2d, 2e, and 2f show axial, sagittal and coronal views for the ADC maps. Figures 2g, 2h and 2i represent the axial, sagittal and coronal views of the avidity of the LF on PSMA PET. Figures 2j, 2k and 2l show the axial, sagittal and coronal views of the fusion of the PSMA PET images to the T2-weighted MR images. Of note, the patient did have a previous transurethral resection of the prostate that was not deemed to be a contraindication to salvage HDR brachytherapy.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us